Characterization of a Clival Chordoma Xenograft Model Reveals Tumor Genomic Instability-Reference-Cited by-同舟云学术

Characterization of a Clival Chordoma Xenograft Model Reveals Tumor Genomic Instability

Published:2018-12 Issue:12 Volume:188 Page:2902-2911
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Diaz Roberto J.^ORCID,Luck Amanda,Bondoc Andrew,Golbourn Brian,Picard Daniel,Remke Marc^ORCID,Loukides James,Sabha Nesrin,Smith Christian,Cusimano Michael D.,Rutka James T.

Funder

German Research Foundation

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference36 articles.

1. Expression pattern of the Brachyury gene in whole-mount TWis/TWis mutant embryos;Herrmann;Development,1991

2. Expression pattern of the mouse T gene and its role in mesoderm formation;Wilkinson;Nature,1990

3. Three-dimensional reconstruction of human embryonic notochords: clue to the pathogenesis of chordoma;Salisbury;J Pathol,1993

4. Classic chordoma coexisting with benign notochordal cell rest demonstrating different immunohistological expression patterns of Brachyury and galectin-3;Shen;J Clin Neurosci,2011

5. Intraosseous benign notochordal cell tumours: overlooked precursors of classic chordomas?;Yamaguchi;Histopathology,2004

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Animal model considerations for chordoma research: reproducing the tumor microenvironment in vivo with humanized mice;Frontiers in Oncology;2024-03-13

2. In vivo efficacy assessment of the CDK4/6 inhibitor palbociclib and the PLK1 inhibitor volasertib in human chordoma xenografts;Frontiers in Oncology;2022-11-25

3. A chronicle review of new techniques that facilitate the understanding and development of optimal individualized therapeutic strategies for chordoma;Frontiers in Oncology;2022-11-16

4. Dramatic In Vivo Efficacy of the EZH2-Inhibitor Tazemetostat in PBRM1-Mutated Human Chordoma Xenograft;Cancers;2022-03-14

5. Personalized chordoma organoids for drug discovery studies;Science Advances;2022-02-18